Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients

Although health authorities have set pharmacogenetic (PGx) markers on labels of hundreds of drugs, the use of PGx in clinical care remains infrequent. The adoption of PGx will depend on the opinions of physicians, pharmacists and patients. Qualitative focus group interviews were performed with 23 ph...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacogenomics 2019-06, Vol.20 (8), p.589-598
Main Authors: Frigon, Marie-Pier, Blackburn, Marie-Ève, Dubois-Bouchard, Camélia, Gagnon, Ann-Lorie, Tardif, Suzie, Tremblay, Karine
Format: Article
Language:English
Subjects:
acceptability
Adult
Aged
Attitude of Health Personnel
Data analysis
Discussion groups
Education
Female
Focus groups
Genetic counseling
Health care
Health Personnel
Humans
implementation
Interviews
Male
Middle Aged
opinions
Patients
Pharmaceuticals
Pharmacists
Pharmacists - psychology
pharmacogenetics
Pharmacogenetics - trends
Pharmacogenomic Testing - veterinary
Physician-Patient Relations
Physicians
Physicians - psychology
Primary care
primary care physicians
Primary Health Care
Professionals
Qualitative research
Studies
Surveys and Questionnaires
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although health authorities have set pharmacogenetic (PGx) markers on labels of hundreds of drugs, the use of PGx in clinical care remains infrequent. The adoption of PGx will depend on the opinions of physicians, pharmacists and patients. Qualitative focus group interviews were performed with 23 physicians, 11 pharmacists and 30 patients. Majority of the participants showed enthusiasm toward the implementation of PGx in clinics. Lack of knowledge on PGx, roles of healthcare providers, factors in favor and challenges of PGx implementation, ethical and insurance issues, educational and tools needs were the key themes that emerged from the interviews. Several barriers impede the uptake of PGx in clinics, however, opinions of physicians, pharmacists and patients are mostly favorable.
ISSN:1462-2416
1744-8042
DOI:10.2217/pgs-2019-0004